You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 7, July 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Immunologic Disorders
 •Alert me on articles by topic

Absence of TH2 Cytokine Messenger RNA Expression in CD30-Negative Primary Cutaneous Large T-Cell Lymphomas

Maarten H. Vermeer, MD; Cornelis P. Tensen, PhD; Petra M. van der Stoop; Hans W. van Oostveen, PhD; Marianne Lund; Rik J. Scheper, PhD; Rein Willemze, MD, PhD

Arch Dermatol. 2001;137:901-905.

Background  Previous studies demonstrating that the neoplastic cells in Sézary syndrome and tumor stage mycosis fungoides express interleukin 4 (IL-4), IL-5, and IL-10 have resulted in the concept that cutaneous T-cell lymphomas are derived from CD4+ T cells with a TH2 type cytokine profile.

Objective  To determine the cytokine profile in CD30- primary cutaneous large T-cell lymphomas, which represent a subgroup of cutaneous T-cell lymphoma with an aggressive clinical behavior (5-year survival rate of 15%).

Design and Methods  Seven biopsy specimens were taken from 4 patients with CD30- primary cutaneous large T-cell lymphomas and studied for the expression of TH1 (IL-2 and interferon {gamma}) and TH2 (IL-4, IL-5, IL-10) cytokines using a reverse transcription–polymerase chain reaction technique. Skin biopsy specimens from patients with Sézary syndrome, mycosis fungoides, atopic dermatitis, or psoriasis were included as controls.

Results  In the 7 CD30- primary cutaneous large T-cell lymphomas showing an almost pure population of large tumor cells (>90%), no expression of IL-4 was found, and IL-5 was only found in 1 of 7 cases. In control biopsy specimens, expression of IL-4 and/or IL-5 was demonstrated in atopic dermatitis (3/3), tumor stage mycosis fungoides (2/2), and Sézary syndrome (3/3), but not in plaque stage mycosis fungoides.

Conclusion  Our results demonstrate that CD30- primary cutaneous large T-cell lymphomas do not produce TH2 cytokines, illustrating that not all cutaneous T-cell lymphomas have a TH2 cytokine profile.


From the Departments of Dermatology (Drs Vermeer, Tensen, van Oostveen, and Willemze and Ms van der Stoop) and Pathology (Drs Tensen, van Oostveen, and Scheper), Free University Hospital, Amsterdam, the Netherlands; and Department of Dermatology, Marselisborg Hospital, Aarhus, Denmark (Ms Lund).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma
Kleinhans et al.
Blood 2003;101:1487-1493.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.